{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T13:50:23Z","timestamp":1723384223882},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1053\/j.semnuclmed.2007.08.002","type":"journal-article","created":{"date-parts":[[2007,10,4]],"date-time":"2007-10-04T07:12:22Z","timestamp":1191481942000},"page":"440-450","source":"Crossref","is-referenced-by-count":28,"title":["3,4-Dihydroxy-6-[18F]-Fluoro-L-Phenylalanine Positron Emission Tomography in Patients With Central Motor Disorders and in Evaluation of Brain and Other Tumors"],"prefix":"10.1053","volume":"37","author":[{"given":"John P.","family":"Seibyl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H.S.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2007.08.002_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(83)91187-3","article-title":"Striatal dopamine metabolism in living monkeys examined by positron emission tomography","volume":"280","author":"Garnett","year":"1983","journal-title":"Brain Res"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/305137a0","article-title":"Dopamine visualized in the basal ganglia of living man","volume":"305","author":"Garnett","year":"1983","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.mibio.2004.05.002","article-title":"Positron emission tomography in clinical neurology","volume":"6","author":"Herholz","year":"2004","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/21548331.1981.11946801","article-title":"Early recognition of Parkinson\u2019s disease","volume":"16","author":"Yahr","year":"1981","journal-title":"Hosp Pract (Off Ed)"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson\u2019s disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib6","first-page":"477","article-title":"Controversies in the therapy of Parkinson\u2019s disease","volume":"69","author":"Fahn","year":"1996","journal-title":"Adv Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.410190410","article-title":"Long-term follow-up of early dopa treatment in Parkinson\u2019s disease","volume":"19","author":"Markham","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000116254","article-title":"Outpatient treatment of Parkinson\u2019s disease","volume":"28","author":"Wermuth","year":"1988","journal-title":"Eur Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib9","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson\u2019s disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib10","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.287.13.1653","article-title":"Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib11","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00702-002-0753-0","article-title":"A comparison of the progression of early Parkinson\u2019s disease in patients started on ropinirole or L-dopa: An 18F-dopa PET study","volume":"109","author":"Rakshi","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson\u2019s disease with ropinirole versus levodopa: The REAL-PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann Neurol"},{"issue":"suppl 4","key":"10.1053\/j.semnuclmed.2007.08.002_bib13","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1212\/WNL.62.6_suppl_4.S27","article-title":"Rapid treatment of \u201cwearing off\u201d in Parkinson\u2019s disease","volume":"62","author":"Swope","year":"2004","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2007.08.002_bib14","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.62.1_suppl_1.S17","article-title":"The origin of motor fluctuations in Parkinson\u2019s disease: importance of dopaminergic innervation and basal ganglia circuits","volume":"62","author":"Obeso","year":"2004","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.20361","article-title":"A responsive outcome for Parkinson\u2019s disease neuroprotection futility studies","volume":"57","author":"Elm","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1474-4422(05)70026-0","article-title":"Treatment for the progression of Parkinson\u2019s disease","volume":"4","author":"Calne","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.291.3.358","article-title":"Neuroprotection in Parkinson disease: Mysteries, myths, and misconceptions","volume":"291","author":"Schapira","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(04)00769-0","article-title":"Disease modification in Parkinson\u2019s disease","volume":"3","author":"Schapira","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(04)00740-9","article-title":"Challenges in Parkinson\u2019s disease: Restoration of the nigrostriatal dopamine system is not enough","volume":"3","author":"Lang","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11910-004-0052-2","article-title":"Neuroprotection in Parkinson\u2019s disease: An elusive goal","volume":"4","author":"Koller","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib21","first-page":"720","article-title":"Drugs in development for Parkinson\u2019s disease","volume":"5","author":"Johnston","year":"2004","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/B:CEMN.0000022764.94760.3f","article-title":"Cell transplantation for Parkinson\u2019s disease: Present status","volume":"24","author":"Drucker-Colin","year":"2004","journal-title":"Cell Mol Neurobiol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2003.08.005","article-title":"Genealogy, expression, and molecular mechanisms in apoptosis","volume":"101","author":"Dlamini","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1474-4422(04)00823-3","article-title":"Neuroprotection and pharmacotherapy for motor symptoms in Parkinson\u2019s disease","volume":"3","author":"Clarke","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ana.410280412","article-title":"Differing patterns of striatal 18F-dopa uptake in Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy","volume":"28","author":"Brooks","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(91)90137-F","article-title":"[125I]RTI-55: A potent ligand for dopamine transporters","volume":"194","author":"Boja","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(93)90061-3","article-title":"Functional imaging in relation to parkinsonian syndromes","volume":"115","author":"Brooks","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF01245007","article-title":"SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT","volume":"94","author":"Brucke","year":"1993","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib29","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1073\/pnas.90.24.11965","article-title":"Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease","volume":"90","author":"Innis","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib30","first-page":"584","article-title":"Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson\u2019s disease and in healthy volunteers","volume":"41","author":"Mozley","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib31","first-page":"999","article-title":"Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson\u2019s disease patients","volume":"44","author":"Huang","year":"2003","journal-title":"J Nucl Med"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2007.08.002_bib32","first-page":"25","article-title":"Detection of preclinical Parkinson\u2019s disease with PET","volume":"46","author":"Brooks","year":"1991","journal-title":"Geriatrics"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/bmj.310.6977.447","article-title":"Parkinsonism\u2014recognition and differential diagnosis","volume":"310","author":"Quinn","year":"1995","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/ageing\/28.2.99","article-title":"Accuracy of diagnosis in patients with presumed Parkinson\u2019s disease","volume":"28","author":"Meara","year":"1999","journal-title":"Age Ageing"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: A clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib37","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/jnnp.56.8.938","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease","volume":"56","author":"Rajput","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib38","first-page":"353","article-title":"The role of neuroimaging in the early diagnosis and evaluation of Parkinson\u2019s disease","volume":"96","author":"Seibyl","year":"2005","journal-title":"Minerva Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/mds.1256","article-title":"[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson\u2019s disease and multiple system atrophy","volume":"16","author":"Varrone","year":"2001","journal-title":"Mov Disord"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10042","article-title":"Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP","volume":"17","author":"Kim","year":"2002","journal-title":"Mov Disord"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.62.3.378","article-title":"Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity","volume":"62","author":"Hilker","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molbrainres.2004.09.028","article-title":"Parkinson\u2019s disease: in vivo assessment of disease progression using positron emission tomography","volume":"134","author":"Au","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/01.WCB.0000126563.85360.75","article-title":"Changes of dopamine turnover in the progression of Parkinson\u2019s disease as measured by positron emission tomography: Their relation to disease-compensatory mechanisms","volume":"24","author":"Sossi","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"issue":"suppl 7","key":"10.1053\/j.semnuclmed.2007.08.002_bib44","first-page":"vII9","article-title":"Neuroimaging trials of Parkinson\u2019s disease progression","volume":"251","author":"Seibyl","year":"2004","journal-title":"J Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib45","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/mds.10531","article-title":"Measuring the rate of progression of Parkinson\u2019s disease over a 5-year period with beta-CIT SPECT","volume":"18","author":"Pirker","year":"2003","journal-title":"Mov Disord"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib46","first-page":"1694","article-title":"Loss of dopamine transporter binding in Parkinson\u2019s disease follows a single exponential rather than linear decline","volume":"45","author":"Schwarz","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib47","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/brain\/awh290","article-title":"Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson\u2019s disease: Implications for dyskinesias","volume":"127","author":"de la Fuente-Fernandez","year":"2004","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/jnnp.74.3.287","article-title":"Objective measures for the progression of Parkinson\u2019s disease","volume":"74","author":"Snow","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib49","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/mds.10592","article-title":"Role of dopamine transporter imaging in routine clinical practice","volume":"18","author":"Marshall","year":"2003","journal-title":"Mov Disord"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00002826-200001000-00007","article-title":"A randomized controlled trial comparing pramipexole with levodopa in early Parkinson\u2019s disease: Design and methods of the CALM-PD Study","volume":"23","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib51","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/mds.10448","article-title":"REAL and CALM: What have we learned?","volume":"18","author":"Morrish","year":"2003","journal-title":"Mov Disord"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.46.1.231","article-title":"[123I] beta-CIT\/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson\u2019s disease","volume":"46","author":"Marek","year":"1996","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib54","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Tredici, Idiopathic Parkinson\u2019s disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib55","first-page":"870","article-title":"Serotonin transporters in the midbrain of Parkinson\u2019s disease patients: a study with 123I-beta-CIT SPECT","volume":"44","author":"Kim","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1176\/jnp.13.2.222","article-title":"In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson\u2019s disease","volume":"13","author":"Murai","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib58","series-title":"Pathology and genetics of tumors of the nervous system","year":"2000"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib59","series-title":"Neurologic complications of cancer","author":"Posner","year":"1995"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib60","series-title":"Pathology and Genetics of Tumors of the Nervous System","author":"Kleihues","year":"2000"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","article-title":"Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas","volume":"64","author":"Kleihues","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib62","first-page":"148","article-title":"Raidiation necrosis or recurrence","volume":"84","author":"Levivier","year":"1996","journal-title":"J Neurosurg"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib63","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s002590100604","article-title":"Anatomical and biochemical investigation of primary brain tumours","volume":"28","author":"Del Sole","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib64","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1200\/JCO.1994.12.9.1886","article-title":"Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma","volume":"12","author":"Watling","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib65","first-page":"1936","article-title":"Re-evaluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo?","volume":"34","author":"Ishiwata","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib66","first-page":"432","article-title":"Radiolabeled amino acids: Basic aspects and clinical applications in oncology","volume":"42","author":"Jager","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib67","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.50.5.1316","article-title":"11C-methionine PET for differential diagnosis of low-grade gliomas","volume":"50","author":"Herholz","year":"1998","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib68","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00259-001-0716-y","article-title":"Fluorinated amino acids for tumour imaging with positron emission tomography","volume":"29","author":"Laverman","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib69","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s002590050541","article-title":"O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: Initial results of a comparative study","volume":"27","author":"Weber","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib70","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00259-003-1259-1","article-title":"Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine","volume":"30","author":"Becherer","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib71","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00259-003-1205-2","article-title":"3-O-Methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging","volume":"30","author":"Bethien-Baumann","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib72","first-page":"904","article-title":"18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy","volume":"47","author":"Chen","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib73","first-page":"432","article-title":"Radiolabeled amino acids: Basic aspects and clinical applications in oncology","volume":"42","author":"Jager","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib74","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM197204272861707","article-title":"Sugar and amino acid transport by cells in culture: Differences between normal and malignant cells","volume":"286","author":"Isselbacher","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib75","first-page":"1030","article-title":"The uptakes of a variety of amino acids into nuclear proteins of tumors and other tissues","volume":"19","author":"Busch","year":"1959","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib76","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00004647-199805000-00005","article-title":"\u201cFacilitated\u201d amino acid transport is upregulated in brain tumors","volume":"18","author":"Miyagawa","year":"1998","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib77","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00259-001-0716-y","article-title":"Fluorinated amino acids for tumor imaging with positron emission tomography","volume":"29","author":"Laverman","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib78","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s00259-004-1512-2","article-title":"Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines","volume":"31","author":"Sasajima","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib79","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0022-510X(95)00117-K","article-title":"Alteration of blood-brain barrier in human brain tumors: Comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET","volume":"132","author":"Roelcke","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib80","first-page":"2116","article-title":"3-O-Methyl-6-18F-fluoro-L-Dopa, a new tumor imaging agent: Investigation of transport mechanism in vitro","volume":"45","author":"Bergmann","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.rcl.2004.09.009","article-title":"PET imaging for differentiating recurrent brain tumor from radiation necrosis","volume":"43","author":"Hustinx","year":"2005","journal-title":"Radiol Clin North Am"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib82","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.nrl.0000080951.78533.c4","article-title":"Cerebral radiation necrosis","volume":"9","author":"Giglio","year":"2003","journal-title":"Neurologist"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib83","first-page":"1861","article-title":"PET in differentiation of recurrent brain tumor from radiation injury","volume":"41","author":"Langleben","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib84","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3171\/jns.2003.98.5.1056","article-title":"Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: Is a differential diagnosis possible?","volume":"98","author":"Tsuyuguchi","year":"2003","journal-title":"J neurosurg"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib85","first-page":"1931","article-title":"Uptake of 18F-fluorocholine, 18F-fluoroehtyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence","volume":"45","author":"Spaeth","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib86","first-page":"470","article-title":"Prognostic value of positron emission tomography with [18F]fluoro-2-D-glucose in the low-grade glioma","volume":"39","author":"De Witte","year":"1996","journal-title":"J Neurosurgy"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib87","first-page":"407","article-title":"Differentiaing recurrent tumor from radiation necrosis: Time for re-evaluation of positron emission tomography ?","volume":"19","author":"Ricci","year":"1998","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib88","first-page":"1180","article-title":"F-Dopa as an amino acid tracer to detect brain tumors","volume":"37","author":"Heiss","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib89","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1470-2045(06)70801-4","article-title":"Staging of carcinoid tumors with 18F-DOPA PET: A prospective, diagnostic study","volume":"7","author":"Koopmans","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib90","first-page":"1455","article-title":"Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?","volume":"47","author":"Montravers","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib91","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2006-1479","article-title":"Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients","volume":"92","author":"Kauhanen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib92","first-page":"560","article-title":"Characterization of hyperinsulism in infancy assessed with PET and 18F-fluoro-L-DOPA","volume":"46","author":"Ribeiro","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib93","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MNM.0b013e328182d606","article-title":"Role of 18F-dopa PET\/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumors","volume":"28","author":"Ambrosini","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib94","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00259-003-1115-3","article-title":"18F-DOPA positron emission tomography for the detection of glomus tumours","volume":"30","author":"Hoegerle","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib95","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002590000404","article-title":"18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels","volume":"28","author":"Hoegerle","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2007.08.002_bib96","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2222010622","article-title":"Pheochromocytomas: detection with 18F DOPA whole body PET\u2014initial results","volume":"222","author":"Hoegerle","year":"2002","journal-title":"Radiology"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299807000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299807000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T10:30:00Z","timestamp":1556879400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299807000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0001299807000888"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2007.08.002","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}